Company Filing History:

13 out of 1,179

Takeda Pharmaceutical Company Limited

patents

12 out of 1,858

Takeda Chemical Industries, Inc.

patents

Years Active: 1998-2015

Loading Chart...

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9157069 - Method of producing pancreatic hormone-producing cells (2015-10-13),

2. 8932853 - Method for manufacturing pancreatic-hormone-producing cells (2015-01-13),

3. 7799533 - Polypeptides, their production and use (2010-09-21),

4. 7662574 - Use of a G protein-coupled receptor and its cognizant ligand in the identification of compounds that affect prolactin secretion (2010-02-16),

5. 7635751 - Peptides having ligand activities on APJ that is an orphan G protein-coupled receptor, and use thereof (2009-12-22),

6. 7410776 - Polypeptides, their production and use (2008-08-12),

7. 7354726 - Screening method (2008-04-08),

8. 7217808 - RFRP-3 and DNA thereof (2007-05-15),

9. 7214495 - Screening method (2007-05-08),

10. 7192723 - G protein-coupled receptor protein, its DNA and ligand thereof (2007-03-20),

11. 7172876 - Method of screening therapeutic agents for nerve degeneration associated diseases (2007-02-06),

12. 7138249 - Screening method (2006-11-21),

13. 7041789 - RFRP-3 and DNA thereof (2006-05-09),

14. 6881545 - Polypeptides, their production and use (2005-04-19),

15. 6794491 - Polypeptides, their production and use (2004-09-21),

Title: **Masaki Hosoya: A Pioneer in Pancreatic Cell Production**

Introduction

Masaki Hosoya, based in Ibaraki, Japan, is a prominent inventor recognized for his significant contributions to the field of biotechnology. With an impressive portfolio of 25 patents, he has focused his research on innovative methods to produce pancreatic hormone-producing cells, a crucial advancement for diabetes treatment and related conditions.

Latest Patents

Hosoya's latest patents include groundbreaking methods for producing pancreatic hormone-producing cells. One patent discloses a technique that mimics pancreatogenesis, allowing for the efficient production of these vital cells. This method involves subjecting stem cells to a series of systematic steps aimed at enhancing differentiation into pancreas cells. Another notable invention provides an advanced procedure for the stable and large-scale production of pancreatic hormone-producing cells, which also includes a medicament containing these cells and a screening method employing them.

Career Highlights

Throughout his career, Hosoya has been associated with esteemed organizations such as Takeda Pharmaceutical Company Limited and Takeda Chemical Industries, Inc. His work at these companies has been pivotal in advancing the understanding and production of pancreatic cells, ultimately contributing to medical innovations in treating pancreatic-related health issues.

Collaborations

Masaki Hosoya has collaborated with esteemed colleagues, including Shuji Hinuma and Ryo Fujii. Their joint efforts have fostered a dynamic research environment, leading to the development of innovative solutions in the field of pancreatic cell production and regenerative medicine.

Conclusion

Masaki Hosoya's work showcases his commitment to advancing biotechnological innovations. His patents represent significant strides in the efficient production of pancreatic hormone-producing cells, which hold great promise for improving treatment options for those affected by pancreatic disorders. His contributions not only demonstrate the power of innovation in science but also highlight the importance of collaboration in achieving groundbreaking advancements.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com